The pharmaceutical giant AstraZeneca has scrapped plans for a £450m expansion of its childhood flu vaccine manufacturing site in Speke, Merseyside, following protracted negotiations with the UK government over state
All posts tagged in corporate investment
2Articles
The recent decision by pharmaceutical giant AstraZeneca to abandon its £450 million investment plan in Liverpool has sparked serious concerns about Britain’s ability to attract and retain major corporate investments.
